Concepedia

Neil Garton

NG

Statistics

Publications

9

Citations

538

H-Index

9

Active since

2009

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

GlaxoSmithKline (Germany)

Walter and Eliza Hall Institute of Medical Research

The University of Melbourne

Neil Garton is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2009–2017

9

Publications

9

Click chemistry enables preclinical evaluation of targeted epigenetic therapies

Dean Tyler, Johanna Vappiani, Tatiana Cañeque et al. · Science · 2017 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Functional interdependence of BRD4 and DOT1L in MLL leukemia

Omer Gilan, Enid Y.N. Lam, Isabelle Becher et al. · Nature Structural & Molecular Biology · 2016 · 124 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +10

Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-<i>d</i>]pyrimidin-4(3<i>H</i>)-one Derivatives

Susan M. Westaway, Alex Preston, Michael D. Barker et al. · Journal of Medicinal Chemistry · 2016 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice

Josefa M. Sullivan, Ana Badimon, Uwe Schaefer et al. · The Journal of Experimental Medicine · 2015 · 66 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor

John Liddle, Francis Atkinson, Michael D. Barker et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 54 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

1–5 of 9